Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 21,535 clinical trials worldwide
Search
Showing 17101-17150 of 21,535 trials
Active filters:
Status: Active, not recruiting
Clinical Trials (21,535)
NCT04115527
Should a Standard Lymphadenectomy Include the No. 16 Lymph Nodes for Patients With Pancreatic Head Adenocarcinoma.
NA
Active, not recruiting
100 participants
Started: Jun 1, 2018 · Completed: Dec 31, 2023
1 condition
1 sponsor
1 location
NCT03566069
Intranasal Oxytocin as Enhancer of Psychotherapy Outcomes in Severe Mental Illness
PHASE2
Active, not recruiting
120 participants
Started: Jun 1, 2018 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT03534635
Analysis of the Modulation of the Tumor Microenvironment by MK-3475 (Pembrolizumab) Using a Systems Biology Approach (PEMSYS)
PHASE2
Active, not recruiting
30 participants
Started: Jun 1, 2018 · Completed: Jun 1, 2026
1 condition
1 sponsor
1 location
NCT03279276
Selecting the Right Hip Prosthesis for Young Patients
NA
Active, not recruiting
60 participants
Started: Jun 1, 2018 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT03589924
Study to Compare the Safety of Immediate One-stage IBBR With Expander-Implant Two-stage IBBR Augmented With TiLoop® Bra(COSTA)
NA
Active, not recruiting
440 participants
Started: Jun 1, 2018 · Completed: Sep 30, 2024
1 condition
5 sponsors
11 locations
NCT03829059
Histological/ Immunohistological and Molecularpathological Types of Epulides and Central Giant Cell Lesions of the Jaws
N/A
Active, not recruiting
83 participants
Started: Jun 1, 2018 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT03491683
INO-5401 and INO-9012 Delivered by Electroporation (EP) in Combination With Cemiplimab (REGN2810) in Newly-Diagnosed Glioblastoma (GBM)
PHASE1/PHASE2
Active, not recruiting
52 participants
Started: May 31, 2018 · Completed: Dec 31, 2025
1 condition
1 sponsor
21 locations
NCT03376672
Ixazomib Plus Lenalidomide Plus Dexamethasone for Newly Diagnosed Myeloma Patients
PHASE2
Active, not recruiting
120 participants
Started: May 31, 2018 · Completed: Dec 31, 2027
1 condition
4 sponsors
26 locations
NCT02825771
Caring Contacts: A Strength-based, Suicide Prevention Trial in 4 Native Communities
NA
Active, not recruiting
711 participants
Started: May 30, 2018 · Completed: Oct 31, 2025
2 conditions
3 sponsors
1 location
NCT03435510
Implementation of the Live Donor Champion Program
NA
Active, not recruiting
111 participants
Started: May 30, 2018 · Completed: Apr 30, 2026
1 condition
1 sponsor
2 locations
NCT03030378
Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors
PHASE1
Active, not recruiting
36 participants
Started: May 30, 2018 · Completed: Dec 1, 2025
2 conditions
1 sponsor
27 locations
NCT03473145
Sedentary Behavior Interrupted Randomized Controlled Trial (P2)
NA
Active, not recruiting
405 participants
Started: May 30, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT03591159
The Effect of Membrane Sweeping on the Delivery Time and the Need of Induction in Term Pregnancy
NA
Active, not recruiting
256 participants
Started: May 29, 2018 · Completed: Dec 1, 2025
1 condition
1 sponsor
1 location
NCT03388190
METIMMOX: Colorectal Cancer METastasis - Shaping Anti-tumor IMMunity by OXaliplatin
PHASE2
Active, not recruiting
80 participants
Started: May 29, 2018 · Completed: Jun 30, 2025
1 condition
5 sponsors
5 locations
NCT03484494
Low Field Magnetic Stimulation: Imaging Biomarkers in Geriatric Bipolar Depression
NA
Active, not recruiting
40 participants
Started: May 29, 2018 · Completed: May 21, 2025
4 conditions
1 sponsor
1 location
NCT04033952
Strategy Training on Improving Executive Functions in Persons Following Acquired Brain Injury
NA
Active, not recruiting
180 participants
Started: May 29, 2018 · Completed: Sep 30, 2024
3 conditions
1 sponsor
3 locations
NCT03410615
Cisplatin + Radiotherapy vs Durvalumab + Radiotherapy Followed by Durvalumab vs Durvalumab + Radiotherapy Followed by Tremelimumab + Durvalumab in Intermediate-Risk HPV-Positive Oropharyngeal SCC
PHASE2
Active, not recruiting
129 participants
Started: May 28, 2018 · Completed: Jul 31, 2026
1 condition
2 sponsors
26 locations
NCT03523858
A Study to Evaluate Ocrelizumab Treatment in Participants With Progressive Multiple Sclerosis
PHASE3
Active, not recruiting
927 participants
Started: May 28, 2018 · Completed: Dec 4, 2026
1 condition
1 sponsor
125 locations
NCT03660124
Deep Brain Stimulation (DBS) for the Treatment of Refractory Alcohol Use Disorder (AUD): Pilot Trial
NA
Active, not recruiting
10 participants
Started: May 25, 2018 · Completed: Dec 25, 2024
1 condition
1 sponsor
1 location
NCT03289299
Aggressive Smoldering Curative Approach Evaluating Novel Therapies and Transplant
PHASE2
Active, not recruiting
87 participants
Started: May 25, 2018 · Completed: Nov 15, 2031
1 condition
5 sponsors
10 locations
NCT03537690
FID-007 in Treating Participants With Advanced Solid Tumors
PHASE1
Active, not recruiting
50 participants
Started: May 25, 2018 · Completed: May 25, 2027
2 conditions
2 sponsors
3 locations
NCT03414866
Thoraflex Hybrid Post-Market Study
N/A
Active, not recruiting
182 participants
Started: May 25, 2018 · Completed: Jul 31, 2026
5 conditions
1 sponsor
7 locations
NCT03919877
Precision Diets for Diabetes Prevention
NA
Active, not recruiting
100 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
3 conditions
2 sponsors
1 location
NCT03645239
Post-operative Emesis and Pain Outcomes After Cesarean Delivery
N/A
Active, not recruiting
595 participants
Started: May 24, 2018 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT06209398
Immunogenicity of the Inactivated EV71 Vaccine Combined With Hepatitis B and Group A Meningococcal Vaccine
PHASE4
Active, not recruiting
510 participants
Started: May 24, 2018 · Completed: Dec 31, 2025
1 condition
2 sponsors
1 location
NCT03561961
Prostate Radiotherapy Comparing Moderate and Extreme Hypo-fractionation (PRIME Trial)
NA
Active, not recruiting
526 participants
Started: May 24, 2018 · Completed: Mar 31, 2035
1 condition
2 sponsors
1 location
NCT03501381
High Dose IL 2 and Entinostat in RCC
PHASE2
Active, not recruiting
46 participants
Started: May 24, 2018 · Completed: Apr 30, 2024
1 condition
4 sponsors
5 locations
NCT02914405
Phase I Study of 131-I mIBG Followed by Nivolumab & Dinutuximab Beta Antibodies in Children With Relapsed/Refractory Neuroblastoma
PHASE1
Active, not recruiting
44 participants
Started: May 24, 2018 · Completed: Nov 30, 2025
1 condition
7 sponsors
3 locations
NCT03533582
Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery
PHASE3
Active, not recruiting
537 participants
Started: May 24, 2018 · Completed: Dec 31, 2026
5 conditions
2 sponsors
205 locations
NCT03645044
Towards a Functional Cure for HBV - The COMMIT Cohort Study
N/A
Active, not recruiting
102 participants
Started: May 24, 2018 · Completed: Jul 31, 2025
2 conditions
8 sponsors
3 locations
NCT03510104
Pharmacokinetic and Safety Study of MRX-2843 in Adults with Relapsed/Refractory Advanced And/or Metastatic Solid Tumors
PHASE1
Active, not recruiting
42 participants
Started: May 22, 2018 · Completed: Apr 30, 2025
6 conditions
1 sponsor
2 locations
NCT04539496
A Phase I/II Study of XZP-3287 in Metastasis Solid Tumors
PHASE1/PHASE2
Active, not recruiting
402 participants
Started: May 22, 2018 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT03452579
Nivolumab Plus Standard Dose Bevacizumab Versus Nivolumab Plus Low Dose Bevacizumab in GBM
PHASE2
Active, not recruiting
90 participants
Started: May 21, 2018 · Completed: Jun 30, 2025
1 condition
1 sponsor
2 locations
NCT03583866
Adiposity and Endothelin Receptor Function
EARLY_PHASE1
Active, not recruiting
25 participants
Started: May 21, 2018 · Completed: Jan 31, 2026
1 condition
2 sponsors
1 location
NCT03417544
Atezolizumab + Pertuzumab + Trastuzumab In CNS Mets In BC
PHASE2
Active, not recruiting
19 participants
Started: May 21, 2018 · Completed: Dec 31, 2025
2 conditions
2 sponsors
2 locations
NCT03528447
The Effect of Pulmonary Rehabilitation on Cognitive Status in Lung Transplantation Candidates
NA
Active, not recruiting
59 participants
Started: May 20, 2018 · Completed: Sep 1, 2025
2 conditions
1 sponsor
1 location
NCT07165093
Diagnostic Yield of Cardiac CT to Detect Cardiac Thrombi in Acute Ischemic Stroke: an Individual Patient Data Meta-Analysis
N/A
Active, not recruiting
3,940 participants
Started: May 19, 2018 · Completed: Sep 1, 2025
4 conditions
1 sponsor
1 location
NCT02892305
Hepatic Resection for Metastatic Pancreatic Cancer
N/A
Active, not recruiting
18 participants
Started: May 18, 2018 · Completed: Jun 30, 2027
3 conditions
1 sponsor
1 location
NCT03520686
Nogapendekin Alfa Inbakicept for Advanced Non-Small Cell Lung Cancer
PHASE3
Active, not recruiting
1,538 participants
Started: May 18, 2018 · Completed: Dec 31, 2026
1 condition
1 sponsor
31 locations
NCT03431363
Medical Cannabis During Chemoradiation for Head and Neck Cancer
N/A
Active, not recruiting
30 participants
Started: May 18, 2018 · Completed: Jan 31, 2026
1 condition
1 sponsor
1 location
NCT03998527
Non-Invasive Spinal Cord Stimulation After Injury
NA
Active, not recruiting
36 participants
Started: May 17, 2018 · Completed: Dec 31, 2029
1 condition
1 sponsor
1 location
NCT04035837
The Clinical Cure Project of Chronic Hepatitis B in China
PHASE4
Active, not recruiting
30,000 participants
Started: May 16, 2018 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT03525288
PSMA-PET Guided Radiotherapy
PHASE2/PHASE3
Active, not recruiting
130 participants
Started: May 15, 2018 · Completed: May 30, 2027
1 condition
2 sponsors
3 locations
NCT03466294
Azacitidine and Venetoclax as Induction Therapy With Venetoclax Maintenance in the Elderly With AML
PHASE2
Active, not recruiting
42 participants
Started: May 15, 2018 · Completed: Oct 31, 2026
1 condition
1 sponsor
1 location
NCT03541902
Cabozantinib or Sunitinib Malate in Treating Participants With Metastatic Variant Histology Renal Cell Carcinoma
PHASE2
Active, not recruiting
32 participants
Started: May 15, 2018 · Completed: Jul 31, 2025
9 conditions
3 sponsors
3 locations
NCT03528694
Assessment of Efficacy and Safety of Durvalumab Plus BCG Compared to the Standard Therapy With BCG in Non-muscle Invasive Bladder Cancer
PHASE3
Active, not recruiting
1,018 participants
Started: May 14, 2018 · Completed: Oct 3, 2028
1 condition
1 sponsor
120 locations
NCT03519230
Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer
PHASE3
Active, not recruiting
224 participants
Started: May 14, 2018 · Completed: Jun 30, 2027
1 condition
1 sponsor
28 locations
NCT03522246
A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy
PHASE3
Active, not recruiting
1,097 participants
Started: May 14, 2018 · Completed: Dec 30, 2030
7 conditions
5 sponsors
238 locations
NCT03572738
Hidradenitis Suppurativa Mail Survey
N/A
Active, not recruiting
67 participants
Started: May 14, 2018 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT03613077
A Non-Interventional Study to Document the Use of Straumann BLX Implants in Daily Dental Practice
N/A
Active, not recruiting
153 participants
Started: May 14, 2018 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
Previous
1
More pages
340
341
342
343
344
345
346
More pages
431
Next